NRX Pharmaceuticals Inc. buy BiotechBee
Start price
10.01.23
/
50%
€1.13
Target price
31.07.24
€2.00
Performance (%)
-49.56%
End price
05.05.23
€0.57
Summary
This prediction ended on 05.05.23 with a price of €0.57. The BUY prediction by BiotechBee for NRX Pharmaceuticals Inc. performed very badly with a performance of -49.56%. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| NRX Pharmaceuticals Inc. | - | - | - | - |
| iShares Core DAX® | 1.001% | 4.831% | 8.149% | 62.596% |
| iShares Nasdaq 100 | 2.702% | -1.720% | 26.924% | 88.135% |
| iShares Nikkei 225® | 3.519% | -3.506% | 48.064% | 78.113% |
| iShares S&P 500 | 1.766% | 1.273% | 23.577% | 70.466% |
According to BiotechBee what are the pros and cons of NRX Pharmaceuticals Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread NRX Pharmaceuticals Inc. diskutieren
Buy mit Kursziel 2,0
In the thread Trading NRX Pharmaceuticals Inc.
Buy beendet

